0001855888-21-000001.txt : 20210420 0001855888-21-000001.hdr.sgml : 20210420 20210419200151 ACCESSION NUMBER: 0001855888-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210420 DATE AS OF CHANGE: 20210419 EFFECTIVENESS DATE: 20210420 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ASCENDIA PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001855888 IRS NUMBER: 862996780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-396377 FILM NUMBER: 21835953 BUSINESS ADDRESS: STREET 1: 661 US HIGHWAY ONE STREET 2: UNIT B CITY: NORTH BRUNSWICK STATE: NJ ZIP: 08902 BUSINESS PHONE: 16099320856 MAIL ADDRESS: STREET 1: 661 US HIGHWAY ONE STREET 2: UNIT B CITY: NORTH BRUNSWICK STATE: NJ ZIP: 08902 D 1 primary_doc.xml X0708 D LIVE 0001855888 ASCENDIA PHARMACEUTICALS, INC. 661 US HIGHWAY ONE UNIT B NEW BRUNSWICK NJ NEW JERSEY 08902 732-640-0058 DELAWARE Ascendia Pharmaceuticals LLC None Corporation true 2021 Jingjun Huang 661 US Highway One Unit B New Brunswick NJ NEW JERSEY 08902 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false 2021-04-07 false true false 949999 Wombat Capital Markets LLC 162699 Wombat Capital Markets LLC 162699 366 Madison Avenue 3rd Floor New York NY NEW YORK 10017 NY NEW YORK false 9999999 4999999 5000000 The offering amount is actually $9,999,999.90, the amount sold to date is $4,999,999.95, and the remaining amount to be sold is $4,999,999.95. false 2 300000 true 0 0 false ASCENDIA PHARMACEUTICALS, INC. Jingjun Huang Dr. Jingjun Huang President and CEO 2021-04-19